Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.946 | 188 | 10 | 1991 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.700 | None | 0.984 | 367 | 3 | 2008 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.972 | 103 | 1 | 1997 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.700 | None | 0.882 | 15 | 2 | 1995 | 2019 | ||||||||
|
nibrin | 0.467 | 0.808 | 2.2E-16 |
|
disease | 0.620 | strong | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.936 | 73 | 2 | 1994 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.600 | None | 1.000 | 32 | 2 | 2005 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.600 | None | 1.000 | 16 | 0 | 1995 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.600 | strong | 0.938 | 15 | 1 | 2001 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.580 | None | 1.000 | 8 | 0 | 1994 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.520 | None | 1.000 | 2 | 0 | 2000 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 204 | 10 | 1988 | 2020 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
disease | 0.500 | None | 1.000 | 24 | 4 | 2009 | 2020 | ||||||||
|
pleckstrin homology like domain family B member 1 | 0.722 | 0.423 | 0.11 |
|
disease | 0.500 | None | 1.000 | 16 | 4 | 2009 | 2020 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
disease | 0.500 | None | 1.000 | 14 | 4 | 2009 | 2020 | |||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.400 | None | 0.980 | 95 | 6 | 1991 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 70 | 0 | 1998 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.979 | 45 | 4 | 2004 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 42 | 0 | 1993 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.893 | 27 | 9 | 2007 | 2019 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 24 | 0 | 2012 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.920 | 24 | 2 | 2001 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.400 | None | 1.000 | 21 | 0 | 1993 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.958 | 21 | 1 | 1994 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.400 | None | 1.000 | 19 | 0 | 2008 | 2018 |